neuraxpharm Arzneimittel GmbH, PRASFARMA, S.L.

Poland

All drugs from this manufacturer

  • GOLPIMEC

    The medicine is used in adults and children and adolescents (over 10 years of age) for the treatment of relapsing-remitting multiple sclerosis (MS), especially in individuals for whom previous treatment has not been effective or in patients with a rapidly progressing, severe form of the disease. It helps to reduce the number of relapses and slow the progression of disability.

    Dosage form: capsules, hard

    Active substance Dosage
    fingolimod 0,50 mg
    fingolimod hydrochloride 0.56 mg

    ATC: L04AA27